Samsung Biologics & Merck’s strategic agreement of manufacturing biologics

Published: 2017-11-03 16:28:00
Updated: 2017-11-03 15:29:23

A pharmaceutical and chemical company Merck announced on the 2nd the company signed a memorandum of understanding(MOU) to agree on strategically manufacture biologics and develop their manufacturing process with Samsung Biologics.

This MOU, an extension of the MOU they established in 2014, conta...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.